Day Zero Diagnostics is pioneering a new class of infectious disease diagnostics using whole-genome sequencing and machine learning to revolutionize how the world fights the growing threat of antibiotic resistance. The company's mission is to change the way infectious diseases are diagnosed and treated by rapidly identifying both the species and the antibiotic resistance profile of severe infections without the need for a culture.

Key Contact

Funding Events

Date	Amount	Type	Investors	Valuation
02/10/22	$21,000,000		Becton, Dickinson and Company Golden Seeds Hongkou Capital Panacea Ventures Sands Capital TriVentures	undisclosed
09/20/23	$16,000,000